Testing NS-079 in healthy volunteers
Treatments studied
This study tests an experimental drug called NS-079 in healthy people to see how safe it is and how the body processes it. It may help researchers learn if the drug could be used for future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 18 and 32.
- You must be in good overall health, with no major medical conditions.
- You must not have taken any other experimental drugs or devices in the past 30 days.
- You must agree to use effective birth control if you are able to have children, or be sterile.
- You must have a specific genetic type (called CYP2D6 normal or intermediate metabolizer) that affects how your body processes certain drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
This study tests a new medication called NS-136 for the first time in people. It aims to see how safe and tolerable the drug is when given to healthy adults. If you are generally healthy, you may be able to take part and help researchers learn about this potential new treatment.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.